Brief: Rigel Pharma Provides Business Update
08/01/2024 17:56
Jan 8 (Reuters) - Rigel Pharmaceuticals Inc RIGL.O :
* RIGEL PHARMACEUTICALS PROVIDES BUSINESS UPDATE
* RIGEL PHARMACEUTICALS INC - EXPECTS TO REPORT NET PRODUCT
SALES
OF $104.3 MILLION IN 2023
Source text for Eikon: ID:nPn3s9wtHa
Further company coverage: RIGL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rigel Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
Rigel Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Rigel Pharmaceuticals Q2 revenue rises on strong product demand
Brief: Rigel Pharmaceuticals - Appoints Alison L. Hannah As Executive Vice President And Chief Medical Officer Effective July 1, 2026 - SEC Filing
Brief: Rigel Announces Closing Of Licensing Agreement For Veppanu (Vepdegestrant)